Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer

由 Escriu, Carles, Field, John K.
發表在 J Thorac Dis (2016)

The potential for using risk models in future lung cancer screening trials

由 Field, John K, Raji, Olaide Y
出版 2010

Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology group

由 Sherratt, Frances C., Newson, Lisa, Field, John K.
發表在 Respir Res (2016)

Risk assessment in relation to the detection of small pulmonary nodules

由 Field, John K., Marcus, Michael W., Oudkerk, Matthijs
發表在 Transl Lung Cancer Res (2017)

Lung cancer screening: identifying the high risk cohort

由 Marcus, Michael W., Raji, Olaide Y., Field, John K.
發表在 J Thorac Dis (2015)

Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial

由 Field, John K., Duffy, Stephen W., Baldwin, David R.
發表在 Transl Lung Cancer Res (2018)

EUPS—argues that lung cancer screening should be implemented in 18 months

由 Field, John K, Baldwin, David R, Devaraj, Anand, Oudkerk, Matthijs
發表在 Br J Radiol (2018)

Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project

由 MARCUS, MICHAEL W, CHEN, YING, DUFFY, STEPHEN W, FIELD, JOHN K
發表在 Oncol Lett (2015)

Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing

由 Shaw, Richard J., Akufo-Tetteh, Emily K., Risk, Janet M., Field, John K., Liloglou, Triantafillos
出版 2006

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

由 Haragan, Alexander, Field, John K., Davies, Michael P.A., Escriu, Carles, Gruver, Aaron, Gosney, John R.
發表在 Lung Cancer (2019)

COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer

由 Oleksiewicz, Urszula, Liloglou, Triantafillos, Tasopoulou, Kalliopi-Maria, Daskoulidou, Nikoleta, Gosney, John R., Field, John K., Xinarianos, George
發表在 J Cancer Res Clin Oncol (2017)

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model

由 MARCUS, MICHAEL W., RAJI, OLAIDE Y., DUFFY, STEPHEN W., YOUNG, ROBERT P., HOPKINS, RAEWYN J., FIELD, JOHN K.
發表在 Int J Oncol (2016)

Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion

由 Field, John K, deKoning, Harry, Oudkerk, Mattijs, Anwar, Sadia, Mulshine, James, Pastorino, Ugo, Eberhardt, Wilfried, Prosch, Helmut
發表在 ESMO Open (2019)

Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review

由 Cheng, Yue I., Gan, Yun Cui, Liu, Dan, Davies, Michael P. A., Li, Wei Min, Field, John K.
發表在 BMC Cancer (2019)

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

由 Brain, Kate, Carter, Ben, Lifford, Kate J, Burke, Olivia, Devaraj, Anand, Baldwin, David R, Duffy, Stephen, Field, John K
發表在 Thorax (2017)

Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: A Case–Control and Cohort Validation Study...

由 Raji, Olaide Y., Duffy, Stephen W., Agbaje, Olorunshola F., Baker, Stuart G., Christiani, David C., Cassidy, Adrian, Field, John K.
出版 2012

P1.04: Defining the Genetic Architecture of Lung Cancer Etiology

由 Amos, Christopher I., Hung, Rayjean, Bosse, Yohan, Christiani, David C., Field, John K., Landi, Maria T., Brennan, Paul B., Mckay, James P.
發表在 J Thorac Oncol (2016)

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

由 Ehrich, Mathias, Nelson, Matthew R., Stanssens, Patrick, Zabeau, Marc, Liloglou, Triantafillos, Xinarianos, George, Cantor, Charles R., Field, John K., van den Boom, Dirk
出版 2005

Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas : Relationship with p53 and MDM2 Protein Expression

由 Gorgoulis, Vassilis G., Zacharatos, Panayotis, Kotsinas, Athanassios, Liloglou, Triantofillos, Kyroudi, Aspasia, Veslemes, Marinos, Rassidakis, Antonios, Halazonetis, Thanos D., Field, John K., Kittas, Christos
出版 1998

DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer

由 Nikolaidis, Georgios, Raji, Olaide Y, Markopoulou, Soultana, Gosney, John R, Bryan, Julie, Warburton, Chris, Walshaw, Martin, Sheard, John, Field, John K, Liloglou, Triantafillos
出版 2012